prolate
发表于 2025-4-1 03:28:05
http://reply.papertrans.cn/24/2377/237699/237699_61.png
abracadabra
发表于 2025-4-1 07:31:53
https://doi.org/10.1007/978-94-009-2717-9nhibitors. Chemotherapy continues to be the mainstay in the treatment of endometrial cancer despite the development of these novel agents. In the future, combining chemotherapy with targeted agents shows promise in improving progression-free survival in patients with endometrial cancer.
NAUT
发表于 2025-4-1 13:32:41
http://reply.papertrans.cn/24/2377/237699/237699_63.png
Calibrate
发表于 2025-4-1 18:02:17
P. T. Tueller (Professor of Range Ecology)rsies regarding the impact of maintenance therapy for treating women with ovarian cancer exist. This chapter details the advantages and disadvantages of continuation medical treatment in newly diagnosed ovarian cancer after primary treatment based on the highest levels of evidence.